Doctors need better guidance on treating ADHD in over 50s

Doctors urgently need better international guidance on treating attention deficit hyperactivity disorder (ADHD) in the over 50s, conclude world-leading experts reviewing current research on this increasing issue globally.

Johnson & Johnson sees highest filings and grants during August in Q3 2023

Share this article Johnson & Johnson has been focused on protecting inventions in United States(US) with 793 publications in Q3 2023 The United States(US) Patent

November 24, 2023

GSK readies Blenrep’s commercial re-launch in the US, and a push in second line

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 18, 2024

New Data on BCMA-Directed Bispecifics in Multiple Myeloma

Promising data on new B-cell maturation antigen (BCMA)-directed bispecific antibodies were presented at the American Society of Clinical Oncology (ASCO) annual meeting. These included results

July 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.